Phase 3 Breast Cancer Trial, Recruiting NCT07024173 Sponsor: Shandong Suncadia Medicine Co., Ltd. Condition: Breast Cancer
Back to Breast Cancer

Phase 3 Breast Cancer Trial, Recruiting

NCT07024173
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between the ages of 18 and 75 (inclusive)
  • People whose general physical health and ability to carry out daily activities falls within a certain functional range, as assessed by a doctor (confirm with trial site)
  • People who have been diagnosed with locally advanced or metastatic breast cancer, confirmed through laboratory testing of tissue samples
  • People who have previously received one or two rounds of hormone-based cancer treatment
  • People whose life expectancy is estimated to be more than 6 months
  • People whose organs (such as liver and kidneys) are functioning at a level that meets the trial's requirements (confirm with trial site)
  • People who are willing to take part voluntarily, are able to follow the trial's visit schedule and procedures, and have signed a consent form after being informed about the study

Who may not be able to join:

  • People whose cancer is progressing quickly in a way that a doctor determines makes hormone-based treatment unsuitable or unlikely to be tolerated
  • People with a history of serious heart or blood vessel disease
  • People experiencing cancer-related pain that cannot be adequately controlled, as determined by a doctor
  • People who have had a serious infection within the 4 weeks before starting the trial treatment
  • People with significant abnormalities of the uterine lining, as identified by a doctor
  • People with active hepatitis that has not been treated
  • People known to be allergic to any components of the study drug HRS-8080
  • Women who are pregnant, breastfeeding, or planning to become pregnant during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86-0518-82342973

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Registry
ClinicalTrials.gov
Start date
23 July 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression free survival (PFS) evaluated by the blinded independent central review (BICR).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov